Podcasts about drug shortages

Drug shortages are a serious public health concern. They can delay or limit a patient's access to effective care, with potentially dire consequences for their health. Over the summer, the Food and Drug Administration was tracking more than 100…

Dr. Angela Fitch, calls in to talk about the weight loss drug shortages and explain what GLP1s are for listeners.

Drug shortages continue to pose significant challenges for hospitals and health systems. While they gained national attention during the COVID-19 pandemic, pharmacy departments have managed them for decades. During high-profile shortages, institutions must rapidly establish command centers, engage stakeholders, and implement plans for frontline staff. Once resolved, shortages often recede from immediate focus until the next crisis emerges. However, pharmacy departments consistently manage shortages on a daily basis, often without recognition. Dr. Kyle Hoelting, Sr. Clinical Manager of Drug Information and Drug Shortages at Vizient, Dr. Heather Warhurst, Director of Drug Use Policy, Quality Initiative and Regulatory at IU Health, and Dr. Chris Nagy, Medication Sourcing and Supply Pharmacist at Intermountain Health join us to discuss a Vizient workgroup project designed to measure the impact of drug shortages and highlight the crucial role of pharmacists in their management.   Guest speakers:  Heather Warhurst, Pharm.D, MHA Director of Drug Use Policy, Quality Initiative and Regulatory IU Health   Chris Nagy, Pharm.D, BCPS Medication Sourcing and Supply Pharmacist Intermountain Health   Kyle Holting, Pharm.D, BCPS Senior Clinical Manager of Drug Information Vizient Center for Pharmacy Practice Excellence   Host: Stacy Lauderdale, Pharm.D, BCPS Associate Vice President Vizient Center for Pharmacy Practice Excellence VerifiedRx Host   Show Notes:  [01:18-02:29] Heather and Chris introductions [02:30-04:00] Vizient drug shortage key performance indicators (KPI) workgroup series [04:01-10:04] Labor and Inventory drug shortage KPIs [07:50-16:56] Patient Safety and Stress to Front Line Staff drug shortage KPIs [16:57-18:32] Call to Action   Links | Resources:  Key performance indicators for the management of drug shortages   Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed

National pharmaceutical associations join forces in identifying solutions for drug shortages. Guest: Angelique Berg - President and CEO, Canadian Association for Pharmacy Distribution Management Learn more about your ad choices. Visit megaphone.fm/adchoices

In this premiere episode, Jessica White, PharmD, VP of Speciality Portfolio & Programs at McKesson, brings over 20 years of experience to the table. From managing oncology's generics portfolio to fostering manufacturer relationships, Jessica shares her unique insights into the strategies that can help navigate drug shortages and ensure continuity in patient care.Tune in as Jessica emphasizes the importance of collaboration among stakeholders to maintain supply chain stability and deliver exceptional care.Check out Jessica's article, Stakeholders Collaborate to Ensure Supply Chain Continuity, where she discusses how effective collaboration can help prevent drug shortages and maintain continuous patient care.

Listen live on the FIVEAA Player. Follow us on Facebook, X and Instagram. Subscribe on YouTubeSee omnystudio.com/listener for privacy information.

The United States faces a critical drug shortage crisis every day that jeopardizes patient care across medical specialties. The problem is staggering: 83 percent of oncologists cannot prescribe their preferred chemotherapy treatments, and a shocking 96 percent of these drug shortages stem from human manufacturing issues. In 2023, drug shortages reached a 10-year high, with 309 critical medications in short supply.These shortages have profound real-world consequences, affecting thousands of patients annually. For Laura Bray, the issue became intensely personal when her nine-year-old daughter was unable to receive her doctor's recommended medicine after being diagnosed with leukemia. Drawing on her personal experience and business management background, Laura was motivated to take action. She founded and is the chief changemaker at Angels for Change, a nonprofit organization committed to ensuring access to lifesaving medications by ending drug shortages. Laura is also an adjunct business professor at Hillsborough Community College. Before academia, Laura worked in marketing strategy and small-business management and consulting.

Data dominate nearly every sector and drug shortages are an area to leverage data solutions. Stephen Colvill, Senior Policy Advisor for Medical Supply Chains, The White House Domestic Policy Council and Dr Nikola Markoski, Vizient Manager of Pharmacy Analytics and Clinical Insights, join host Gretchen Brummel to explore novel approaches and future implications for data use cases in drug shortages.   Guest speakers:  Stephen Colvill Senior Policy Advisor for Medical Supply Chains, Domestic Policy Council The White House, Domestic Policy Council This podcast was recorded in December 2023 prior to Stephen joining the federal government. The opinions expressed are the author's own and do not necessarily reflect the views of  the United States government or any agency thereof. At the time of recording, Stephen was Executive Director of RISCS and Assistant Research Director at the Duke-Margolis Institute for Health Policy.   Nikola Markoski, PharmD, MBA, DPLA Manager of Pharmacy Analytics and Clinical Insights Vizient   VerifiedRx Host:  Gretchen Brummel, PharmD, BCPS   Show Notes:  [00:36-02:23] Guest's background information  [02:24-05:44] How using data can change the discussion of drug shortages [05:45-09:23] Approaches that have been attempted so far in the data space [09:24-12:01] Where things are going in the future [12:02-15:23] How we get everybody on the same page   Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed

Virginia’s congressional delegation is hoping to make some bipartisan accomplishments in the lame duck Congress. Michael Pope reports on one of the efforts.

A new study published in JAMA found that drug-related supply chain issue reports were 40% less likely to result in meaningful drug shortages in Canada compared with the US. Authors Kate Suda, PharmD, MS, of University of Pittsburgh School of Medicine, and Mina Tadrous, PharmD, PhD, of University of Toronto, discuss this and more with JAMA Deputy Editor Joseph S. Ross, MD, MHS. Related Content: Differences in Drug Shortages in the US and Canada Understanding Drug Supply Shortages in the US and Canada

A large portion of the prescription medication American's consume are generic. But with many of the active ingredients being sourced and manufactured in other countries, are our federal oversights enough protection? This week, our expert explains the systems in place – as well as their weaknesses and strengths. Learn More: https://radiohealthjournal.org/generic-drugs-the-industry-secrets-that-can-lead-to-drug-shortages Learn more about your ad choices. Visit megaphone.fm/adchoices

Where did Hurricane Helene hit? Why is there a shortage of intravenous fluids? What can I use instead of IV saline? Where are IV bags made? AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, discusses the impact of Hurricane Helene, how elective surgery can be delayed after the North Carolina hurricane damage, and addressing drug shortages in the US. American Medical Association CXO Todd Unger hosts.

It can be frustrating when medication shortages impact access to essential healthcare. Host Jean Fisher-Brinkley discusses a range of possible solutions with Jay Campbell, Executive Director at the North Carolina Board of Pharmacy. Find out what steps healthcare consumers and providers can take in such situations. Visit our show page for resources mentioned in this episode.Host: Jean Fisher BrinkleyGuest: Jack W. “Jay” Campbell IV, JD, RPh, Executive Director at the North Carolina Board of PharmacyProducer: Sylvia French-HodgesFollow the North Carolina Medical Board on X, Facebook, and LinkedIn.Email your questions to: podcast@ncmedboard.org.

Karl and Erum welcome Christina Smolke, CEO of Antheia and Professor at Stanford University, to discuss the rapid changes happening in biotech, particularly focusing on the biohacking community and decentralized science (DCI). Christina is developing revolutionary ways to manufacture critical pharmaceuticals using biotechnology. They explore the intersection of biohacking, pharmaceuticals, and emerging technologies. A key theme is the potential of biological processes to transform traditional methods, such as growing plants for medicine, into faster, scalable alternatives. Karl, Erum, and Christina talk about cutting-edge topics like longevity, decentralized research, and biotech's growing role in addressing global challenges such as drug shortages and sustainability. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Chapters: 00:00:00 – Biotech Beginnings: Kicking off with the latest innovations in biotech. 00:00:16 – Event Recap Madness: A whirlwind of the hottest biotech events. 00:00:49 – Sci-Fi or Science?: Diving into decentralized science's wild future. 00:02:45 – The Vital Shift: Key moments from the cutting-edge biohacking event. 00:07:21 – DARPA's Big Moves: How AI and biotech are shaping the future of defense. 00:09:21 – A Conversation with Christina Smolke: Enter the world of biotech innovation with Antheia's visionary. 00:17:21 – The Manufacturing Dilemma: Tackling the challenges in pharmaceutical production. 00:28:14 – Antheia's Game-Changing Role: Transforming the pharmaceutical landscape. 00:29:22 – Supply Chain Solutions: Ensuring surety of supply for critical drugs. 00:30:22 – Biotech Scaling Mastery: How Antheia is leading synthetic biology to new heights. 00:35:23 – Government Backing Biotech: Why the U.S. is investing in synthetic biology. 00:39:10 – The Future of Pharma Manufacturing: Leapfrogging into more sustainable, faster production methods. 00:47:39 – Wisdom for Biotech Founders: Christina's must-hear advice for new leaders. 00:49:44 – Key Takeaways: Recapping the interview with reflections and insights. 00:53:02 – Tackling Drug Shortages: Addressing the global crisis with biotech innovation. 00:54:29 – Closing Connections: Final thoughts and how you can join the conversation. Topics Covered: biotech, bioengineering, precision fermentation, epigenetics, optogenetics, light, biosolutions, cellular control, photomolecular biology Episode Links: Antheia  DARPA Biological Technologies Office  JP Morgan Healthcare Conference DeSciNYC Compound VC Union Square Ventures Unnatural Selection on Netflix Josie Zayner David Cronenberg  Scavengers Reign animated series⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowEverything website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email: groweverything@messaginglab.com Music by: Nihilore Production by: Amplafy Media

We discuss how the shortage of chemotherapy drugs stems from economic challenges faced by generic drug manufacturers. Many cannot afford to produce these drugs due to low profitability. Factors include factory shutdowns for quality issues, a complex global supply chain, and older generic drugs being unprofitable to produce. Government pressure on prices further reduces profit margins, disincentivizing investment in production quality. Consequently, manufacturers prioritize newer, more expensive drugs, leading to treatment delays and stress for patients. Support the Show.

In this episode, Scott Becker is joined by Paige Twenter, Assistant Editor at Becker's Healthcare, to discuss the latest in healthcare pricing controversies, Mark Cuban's Cost Plus Drugs initiative, and ongoing drug shortages. Paige provides insights into the pricing debates surrounding GLP-1s, the expansion of affordable drug access, and the critical issue of oncology drug shortages affecting hospitals and patients nationwide.

If you've tried to get prescriptions filled in the last year or so, a pharmacist may have told you, “Sorry, we don't have that drug right now.” That's because there are some 323 active and ongoing drug shortages in the United States. That's the highest number of such shortages since the American Society of Health System Pharmacists started tracking this data back in 2001.These drug shortages touch every part of the healthcare system. Doctors are having to reconfigure their treatment plans due to short supply of certain drugs, like cancer treatments. And patients can be left going from pharmacy to pharmacy to get even the most common medications, like antibiotics.SciFri's John Dankosky talks with freelance journalist Indira Khera and journalist and physician Dr. Eli Cahan, who looked into why drug shortages happen, how they're affecting the healthcare system, and what solutions are on the horizon.Transcripts for each segment will be available after the show airs on sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

In this episode, Scott Becker is joined by Paige Twenter, Assistant Editor at Becker's Healthcare, to discuss the latest in healthcare pricing controversies, Mark Cuban's Cost Plus Drugs initiative, and ongoing drug shortages. Paige provides insights into the pricing debates surrounding GLP-1s, the expansion of affordable drug access, and the critical issue of oncology drug shortages affecting hospitals and patients nationwide.

Dr Hadar Elbaz, DACM, AP, Diplo.O.M., Director of Functional Medicine TWC. twc.health/GRUBER, promo code: GRUBER.   1.Recently the former CDC Director said a bird flu pandemic is a question of when not if. Is this just the start of the scare tactics? 2. If they are right and we could see a pandemic what could people do to stay safe and avoid another experimental vaccine? 3. Speaking of experimental vaccine, recently the state of Kansas announced a lawsuit against Pfizer claiming their vaccine didn't work, is dangerous and they knew it was dangerous. Is the damn finally breaking? 4. For people who were vaccinated and who are worried about the side effects of that vaccine, what can they do? 5. A new study out shows that prescription drug shortages are at the highest level in decades.

Leigh Feldman joins Priya Rathakrishnan to discuss the federal policies that currently exist to address drug shortages.

DRUG SHORTAGES IN THE U.S. ARE AT AN ALL-TIME HIGH, WITH LOW SUPPLIES OF EVERYTHING FROM LIFE-SAVING INJECTIONS TO DIABETES MEDICATIONS; AFFECTING HOSPITALS, PHARMACIES AND PATIENTS AROUND THE COUNTRY. WE TALK WITH DR. SHAWN ROWLAND, FOUNDER & CEO OF JASE MEDICAL.

Members of Congress are increasingly focused on addressing drug shortages. Tom Kraus and Michael Ganio discuss a new bipartisan proposal that would use payment incentives to shift purchasing behavior to mitigate drug shortages.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This is the AHRMM Power Up Podcast with Mike Schiller and hosted by Justin Poulin. Every month, we highlight trends, strategies, and solutions from the field to advance the healthcare supply chain industry. In this episode, Mike and Justin share what you need to know from May '24: New HHS Proposal for Drug Shortages --includes penalties Review of AHA's position and AHRMM's released statement Supply Chain Fundamentals Series NEW, 30-minute e-learning course on the FAHRMM 0.5 CEC, FREE members/non-members FAHRMM guidelines have changed -- Aligned more with the current environment Panama Canal is Opening Back Up! #AHRMM #PowerSupply #Podcast #HealthcareSupplyChain #MayUpdate ________ Power Supply is proud to partner with AHRMM, the leading professional membership group for the healthcare supply chain. Through this collaboration, Power Supply offers Continuing Education Credit (CEC) approved podcast episodes to the healthcare supply chain audience.

We discuss how recent shortages of chemotherapy drugs like cisplatin and carboplatin have caused delays and changes in treatment plans for some cancer patients. While the situation is improving, shortages still exist for some drugs. Staying informed is crucial, and the FDA is actively tracking drug shortages to mitigate them. It's important to communicate with your doctor, who can provide the latest information and discuss alternative treatment options tailored to your needs. Support the Show.

This is the AHRMM Updates Podcast with Mike Schiller and hosted by Justin Poulin. Tune in every month as we highlight trends, strategies and solutions from the field to advance the healthcare supply chain. And now, Mike and Justin… May ‘24 Update: - HHS Proposal for Drug Shortages includes penalties * Review of AHA's position and AHRMM's released statement - Supply Chain Fundamentals Series * Another 30-minute e-learning course on the FAHRMM * FAHRMM guidelines have changed - Panama Canal is Opening Back Up!

Hour 1 of The Drew Mariani Show on 5-14-24 Drew takes us through a few headlines in today's News Roundup Peter Breen from The Thomas More Society joins us for a discussion around suing New York State and Pro-Lifers' sentencing Deacon Ronald Reimer helps us understand what's happening with drug and prescription shortages around the country

Episode 24 of The Pound of Cure Weight Loss podcast is titled, Zepbound to happen: More Drug Shortages. The title comes from our Economics of Obesity segment where we discuss the Zepbound shortages and offer strategies that you can use to ride out the shortage.  In our In the news segment, we discuss an article from the New York Times titled, The Miracle Weight-Loss Drug Is Also a Major Budgetary Threat. In the United States, we pay more for medication than any other country in the world - often 3-4 times more. So, what can we do to bring those prices down? Tune in to find out!In our Patient Story, we talk to Janet who started gaining weight after pregnancy. She lost well over 100 pounds on Mounjaro and is currently using a creative dosing strategy to save money during maintenance. For the first few months after surgery and while taking a GLP-1 medications, you might not feel like eating but your body still needs fuel. So, in our Nutrition segment, Zoe offers advice about what to do when you just don't feel like eating.Finally, we answer 3 of our listeners' questions including, how to transition from weight loss to weight maintenance, why does a revision carry more risk, and how to keep your set point lower while on weight gaining medications.

Inside Edition Host Deborah Norville discusses her report on why men are turning to cosmetic procedures and the measures people are taking to obtain weight-loss drugs in short supply. ABC News Tech Reporter Mike Dobuski explains why sales of Apple's Vision Pro failed to meet expectations and why Ford's driver-assistance system is under investigation.

Protests on college campuses continue to grow overnight as university leaders struggle to contain escalating tensions. Also, the Supreme Court is set to hear arguments on Donald Trump's Presidential immunity case. Plus, an American tourist is facing up to twelve years in prison after authorities in Turks and Caicos find ammo in their luggage. And, In-depth TODAY: With summer approaching, concern is growing over rising shortages in weight loss drugs. 

A major 911 call outage overnight impacts several states, leaving emergency responders scrambling for hours. Also, TODAY consumer: Many customers are facing shortages on weight loss drugs likes Zepbound. Plus, Orlando Bloom live in studio 1a to catch up and discuss his new Peacock series “To The Edge.” And, chef Mario Carbone cooks up a delicious Italian classic chicken parm recipe. 

Dr. Jim Adams, Chief Medical Officer of Northwestern Medicine, joins Lisa Dent to explain why drug shortages in the U.S. have reached an all-time high and how long it could take for drug makers to resupply. Also, Dr. Adams explain why it might be time for schools to stop serving the popular kids snack Lunchables. “Better […]

Dr Michael Ganio joins Ethics Talk to discuss his article: “How Should We Draw on Pharmacists' Expertise to Manage Drug Shortages in Hospitals?”  Recorded January 25, 2024.  Read the full article for JournalofEthics.org

  Joseph J. Fallon, Jr., M.D. updates us on animal bites, current drug shortages, and weight loss drug efficacy gains – a brighter future. The post Dr Joseph J Fallon on Animal Bites, Drug Shortages, Weight Loss Drugs and More 04-13-24 appeared first on WWDB-AM.

Israel is preparing for a potential attack by Iran or its proxies as soon as this week. The House passed a modified surveillance bill after it failed earlier this week. A former US diplomat accused of spying for Cuba is expected to be sentenced today. Drug shortages reached a record high in the US. And, the head of the largest US bank is painting a gloomy outlook on America's economic future. Learn more about your ad choices. Visit podcastchoices.com/adchoices

April 12, 2024 ~ Have you had problems filling your prescriptions lately? The American Society of Health says drug shortages in the U.S. are at an all-time high, with 323 commonly used medications hard to find. WJR Senior News Analyst Marie Osborne talks with Guy, Lloyd, and Jamie about what's behind the trend.

April 12, 2024 ~ Senior News Analyst Marie Osborne discusses the drug shortage which is reaching crisis levels.

This week I talk about the medication shortages across the United States. Drugs used to treat ADHD, chronic pain, and other conditions have been in short supply lately for reasons unexplained. Different groups have blamed the shortage on one anther: the manufacturers blame the DEA, while the DEA blames manufacturers. But as usual, the problem comes down to a design issue.  For more about Assent's issues with the DEA, check out the Reason article, "DEA Shuts Down Factory even as Adderall Shortage Persists." Support the show

What factors are increasing demand and how long could shortages continue?

Plus: The State Department is investigating whether Israel misused U.S.-supplied weapons to kill civilians. Eurozone manufacturing jumped unexpectedly in December. J.R. Whalen reports. Learn more about your ad choices. Visit megaphone.fm/adchoices

On this Episode of the ASC Podcast with John Goehle we discuss the Latest News, the impact on ASCs of the ongoing Drug Shortages, recent state actions impacting ASCs including price transparency initiatives and in our focus segment, we discuss profitability challenges related to on-going salary, and other cost pressures and Interview triValence's Alex Pirrotta regarding supply chain costs.    This episode is sponsored by triValence.   Notes and Resources from this Episode: ECRA and ISMP Report: https://assets.ecri.org/PDF/10.2023_Press_Release_Medication_Shortages_supporting_summary.pdf For more on managing drug shortages, visit ISMP website: www.ismp.org/node/775 For more on managing supply and device shortages, visit ECRI website: www.ecri.org/supply-chain-disruption-in-healthcare The ASC Association (ASCA) Please become a member and support the Association that supports the ASC Industry: https://www.ascassociation.org/asca/membership/join-renew Ozempic and other GLP-1 Drugs (Article from Beckers Spine) https://www.beckersspine.com/spine/58359-will-ozempic-alter-spine-orthopedic-fields.html?origin=ASCE&utm_source=ASCE&utm_medium=email&utm_content=newsletter&oly_enc_id=0573H1191845C8E Signup for Becker's Spine: https://www.beckersspine.com/e-weekly/spine-review-e-weekly.html OR Manager article about RN Salaries:https://www.ormanager.com/briefs/rns-expected-to-see-big-salary-bump-by-2033-due-to-nursing-demand/#:~:text=RNs%20made%20%2433.13%20in%20hourly,occupational%20fields%20in%20the%20country. triValence:http://trivalence.com DON'T MISS OUR UPCOMING CREDENTIALING, PRIVILEGING AND PEER REVIEW VIRTUAL CONFERENCE! INFORMATION ABOUT THE ASC PODCAST WITH JOHN GOEHLE ASC Central, a sister site to http://ascpodcast.com provides a link to all of our bootcamps, educational programs and membership programs! http://asc-central.com Join one of our Membership Programs! Our Patron Program:Patron Members of the ASC Podcast with John Goehle have access to ASC Central - an exclusive membership website that provides a one-stop  ASC Regulatory and Accreditation Compliance, Operations and Financial Management resource for busy Administrators, nurse managers and business office managers.  More information and Become Member The ASC-Central Premium Access Program A Premium Resource for Ambulatory Surgery Centers including access to bootcamps, education programs and private sessions More Information and Become a Premium Access Program Members Today! Important Resources for ASCs: Conditions for Coverage: https://www.ecfr.gov/cgi-bin/text-idx?c=ecfr&rgn=div5&view=text&node=42:3.0.1.1.3&idno=42#se42.3.416_150 Infection Control Survey Tool (Used by Surveyors for Infection Control)https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/som107_exhibit_351.pdf Updated Guidance for Ambulatory Surgical Centers - Appendix L of the State Operations Manual (SOM)https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/som107ap_l_ambulatory.pdf https://www.cms.gov/medicareprovider-enrollment-and-certificationsurveycertificationgeninfopolicy-and-memos-states-and/updated-guidance-ambulatory-surgical-centers-appendix-l-state-operations-manual-som Policy & Memos to States and RegionsCMS Quality Safety & Oversight memoranda, guidance, clarifications and instructions to State Survey Agencies and CMS Regional Offices. https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Policy-and-Memos-to-States-and-Regions Other Resources from the ASC Podcast with John Goehle: Visit the ASC Podcast with John Goehle Website Books by John Goehle Get a copy of John's most popular book - The Survey Guide - A Guide to the CMS Conditions for Coverage & Interpretive Guidelines for Ambulatory Surgery Centers 

RSV infections are not new and have devastating impacts. The recent advent of new prevention strategies has renewed the focus on the disease with a hopeful outlook. For the last 25 years, the only FDA approved product preventing RSV, lower respiratory tract disease, was palivizumab or Synagis, a monoclonal antibody indicated for use in high risk infants children and administered intramuscularly monthly throughout the RSV season. In May, the first ever RSV vaccines were approved, Arexvy and Abrysvo. These two new RSV vaccines were approved for use in adults greater than or equal to 60 years of age. In August this year, one of the RSV vaccines, Abrysvo, also received approval for expanded use for maternal vaccination to prevent RSV lower respiratory tract disease in infants. Nirsevimab or Beyfortus, a new long-acting monoclonal antibody, was approved in July for prevention of RSV lower respiratory tract disease in infants and children. Compared with palivizumab, nirsevimab is indicated for a much broader patient population including recommended use in all infants less than eight months of age, born during or entering their first RSV season. The rollout of nirsevimab has proved challenging due to supply shortages, among other factors. Today we discuss the new RSV prevention strategies, focusing on the pediatric patient population, as well as the recent shortages with nirsevimab. Dr. Deb Bondi, Dr. Nikolai Dahl, as well as Dr. Kyle Hoelting from Vizient join guest host Vizient's John Schoen for today's podcast.   Guest speakers:  Deb Bondi, PharmD, FCCP, BCPS, BCPPS Pediatric Clinical Coordinator, NICU Clinical Pharmacy Specialist, and PGY2 Pediatric Pharmacy Residency Program Director UChicago Medicine, Comer Children's Hospital   Nikolai Dahl, PharmD Utilization and Formulary Program Manager John Muir Health   Kyle Hoelting, PharmD, BCPS Senior Clinical Manager of Drug Shortages and Drug Information Vizient Center for Pharmacy Practice Excellence    Host:  John Schoen, PharmD, BCPS  Senior Clinical Manager of Evidence-Based Medicine and Drug Information Vizient Center for Pharmacy Practice Excellence   Show Notes:  [02:39-04:09] Update on where everything currently stands with the Nirsevimab supply and what led to the shortage [04:10-05:01] Information on whether or not there's going to be additional supply of either the 50 mg or 100 mg syringes later this season [05:02-06:01] Resources related to mitigating this nirsevimab shortages [06:02-10:29] What University of Chicago and John Muir Health are doing with these new RSV vaccines and the new monoclonal antibody, Beyfortus [10:30-13:15] Formulary decisions University of Chicago and John Muir Health make around nirsevimab and palivizumab [13:16-15:24] Organizational preference for the maternal RSV vaccine or nirsevimab [15:25-20:33] Other logistical issues with either nirsevimab or the maternal RSV vaccines, such us scope of practice consideration, stocking of the VFC product in patient education, et cetera [20:34-22:01] Payment of billing issues either University of Chicago or John Muir Health experienced for either nirsevimab or the maternal RSV vaccine [22:02-24:57] Clinical pearls or advice related to these new prevention strategies   Links | Resources: Vizient member RSV resources RSV vaccines in adults side-by-side comparison RSV monoclonal antibodies in pediatrics side-by-side comparison FAQ pediatric RSV prevention strategies Minute Market Insight on nirsevimab shortage Mitigation strategy on nirsevimab shortage   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Android RSS Feed

We want to learn more about you! Please tell us a bit about yourself by participating in a brief survey at cnn.com/audie -- and thank you! ---- How does ageism impact all of us? What is causing the chemotherapy drug shortage?  These questions come from you, our listeners, who call in week after week with ideas for our next assignment. This week Audie speaks with CNN Health reporter Jacqueline Howard and Gerontologist Dr. Tracey Gendron about the future of ongoing pharmaceutical drug shortages and the impact ageism could have on the 2024 presidential election.   If you have an assignment you'd like us to look into, leave us a voicemail at 202-854-8802 and you might just hear your voice on an upcoming episode!  Learn more about your ad choices. Visit megaphone.fm/adchoices

We want to learn more about you! Please tell us a bit about yourself by participating in a brief survey at cnn.com/audie -- and thank you! ---- How does ageism impact all of us? What is causing the chemotherapy drug shortage?  These questions come from you, our listeners, who call in week after week with ideas for our next assignment. This week Audie speaks with CNN Health reporter Jacqueline Howard and Gerontologist Dr. Tracey Gendron about the future of ongoing pharmaceutical drug shortages and the impact ageism could have on the 2024 presidential election.   If you have an assignment you'd like us to look into, leave us a voicemail at 202-854-8802 and you might just hear your voice on an upcoming episode!  Learn more about your ad choices. Visit megaphone.fm/adchoices

Today On Medical Grounds, we will be speaking with Dr. Heather Whitley. Dr. Whitley is a clinical professor in the Department of Pharmacy Practice at the Auburn University Harrison College of Pharmacy. She is a board certified pharmacotherapy specialist and a certified diabetes educator. Earlier this year, Dr. Whitley spoke with us about screening for diabetes in high-risk individuals. Today, she is back to talk about some new things going on in the diabetes and pharmacy world. This is part 1 of a two part series. In Part 1, Dr. Whitley will be discussing shortages in GLP-1 agonist drugs for diabetes and what pharmacists can do to address those shortages.Dr. Whitley recently published a paper in Clinical Diabetes about this topic:Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages(00:09) Introduction to Dr. Whitley(01:08) Publication on strategies for GLP-1 and GLP-1/GIP shortages(02:36) GLP-1 and GLP-1/GIP agonists, names, and dosing(04:15) Why are there shortages?(08:52) Alternatives(10:11) What happens if a patient misses a dose?(12:19) Re-initiation of medications(14:51) GLP-1 agonist equivalency(15:31) Substituting SGLT2s(17:16) Self-sourcing or online sourcing problems(21:51) Managing patient expectations and concernsVisit us at OnMedicalGrounds.com for more podcasts! You can subscribe through your podcast platform, our website, or follow us on social media for podcast updates and medical news. Some of our podcasts offer FREE CME/CE credits.LinkTreeTwitterLinkedInInstagram

Today On Medical Grounds we will be speaking with Dr. Heather Whitley for part two of our discussion. Dr. Whitley is a Clinical Professor in the Department of Pharmacy Practice at the Auburn University Harrison College of Pharmacy. She is a Board Certified Pharmacotherapy Specialist and a Certified Diabetes Educator. Earlier this year, Dr. Whitley spoke with us about screening for diabetes in high-risk individuals. Dr. Whitley is well published—predominantly in diabetes related research. In part 1 we explored options for patients with diabetes who can't obtain their GLP-1 receptor agonist drugs due to a nationwide storage. In part 2 we expand this conversation by bringing in the concept of pharmacy deserts and the pharmacist's role in patient care.Dr. Whitley has provided us with two websites that can be used by patients to determine whether there is a shortage of their medications:FDA Drug Shortageshttps://www.fda.gov/drugs/drug-safety-and-availability/drug-shortages ASHP Current Drug Shortages https://www.ashp.org/drug-shortages/current-shortages(00:22) General drug shortages(03:09) What drugs are currently in short supply?(04:46) What can patients do about shortages?(07:40) Ideas to boost supply(09:34) Pharmacy deserts(14:23) Amazon Pharmacy: friend or foe(15:40) What can pharmacists do for patient care?Visit us at OnMedicalGrounds.com for more podcasts! You can subscribe through your podcast platform, our website, or follow us on social media for podcast updates and medical news. Some of our podcasts offer FREE CME/CE credits.LinkTreeTwitterLinkedInInstagram

Shortages of over-the-counter drugs and prescription medications for ADHD, cancer and diabetes have been disrupting hospitals and pharmacies for the past year. Now, RSV treatments for infants are the latest to be affected. Michael Ganio, a senior director at the American Society of Health-System Pharmacists, joins Ali Rogin to discuss what's driving the shortages and what can be done about it. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

Current FDA commissioner, Robert Califf, joins the show to cover his story – from his career path to his crucial role today. Join Chadi in this eye-opening episode as they uncover the complexities of drug shortages in the United States, especially in the realm of cancer treatment. Learn about the intricate web of factors contributing to drug shortages, how cancer drug scarcities emerged, and the FDA's pivotal role in addressing them. Dr. Califf shares strategies to mitigate these issues, emphasizing the importance of supply chain nuances and more. Tune in to gain unique insights into the FDA's commitment to patients and the future of cancer care. Read more about the cancer drug shortage. https://www.theatlantic.com/health/archive/2023/06/cancer-drug-market-dysfunction-supply-shortage/674512/ https://www.axios.com/2023/06/14/cancer-drug-shortages-supply-chain-vulnerabilities https://ascopubs.org/doi/full/10.1200/OP.21.00883 Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

Did you know that the pandemic caused a spike in ADHD evaluations? Or that it's led to a nationwide shortage in ADHD medications? Join Dr. Imani and Meg Scoop as they discuss the impact of Adult ADHD and why it's still on the rise. Plus, the ladies perform a pop culture diagnosis on Dre of Donald Glover's 'Swarm' show! If you'd like to submit a listener letter of your own, please email us at hello@imanistateofmind.com.This show is part of the Spreaker Prime Network, if you are interested in advertising on this podcast, contact us at https://www.spreaker.com/show/5754867/advertisement

Drug shortages near all-time highs; Democratic parents in California push back against transgender policies for minors; and funeral homes near the southern border bear the burden of laying deceased migrants to rest. Plus, a plane loses its emergency slide mid-flight, commentary from Cal Thomas, and the Thursday morning newsSupport The World and Everything in It today at wng.org/donate.Additional support comes from Covenant College: Christ-centered community and quality education that equips students for calling and career. More at covenant.edu/WORLDFrom Building Worldviews, a podcast dedicated to thoughtful dialogue about life's deepest questions. Building Worldviews … wherever you get your podcasts or at praxiscircle.com.And from Ridge Haven Camp and Retreat Centers, hosting youth and campus groups year-round in Brevard North Carolina and Cono Iowa. More at ridgehaven.org

The political engagement of religious and non religious groups, critical drug shortages in several categories, and childhood obesity around the world. Get the facts first with Morning Wire. Contingency Medical: ​​Get $20 off any Contingency Medical Pack! Use promo code WIRE at http://www.ContingencyMedical.com